Night Shifts Can Disrupt DNA Repair—What the Evidence Actually Shows
Evidence available today supports a narrower and more useful conclusion than the claim that night work “changes your DNA.” Overnight schedules and severe sleep loss can disrupt the timing of DNA-repair activity and increase measured signs of DNA damage, but that is not the same as proving a permanent mutation, an inherited alteration, or cancer in an individual worker.
Research published since the initial 2019 report has strengthened the proposed biological mechanism under controlled conditions. A small 2025 trial also tested melatonin against one repair biomarker, but it did not establish cancer prevention or justify routine self-treatment. The practical concern remains repeated circadian disruption and insufficient recovery, not a single late evening at a desk.
What researchers actually found in night workers
The study behind many alarming headlines examined a specific population rather than everyone who occasionally works late. A 2019 observational study of 49 doctors compared healthy full-time physicians who worked overnight on-site calls with colleagues who did not. Twenty-four overnight-call participants also provided blood after acute sleep deprivation.
The overnight-call group had lower baseline expression of DNA-repair genes and more DNA breaks. Among those sampled after a sleep-deprived shift, repair-gene expression decreased while measured breaks increased further. The authors described an association and explicitly called for larger prospective studies to determine whether these laboratory findings translate into chronic disease.
A later experiment separated schedule timing from many features of real workplaces. In a 2021 controlled laboratory study, 14 healthy adults were assigned to three days of simulated day or night shifts. Researchers then collected blood every three hours during a constant-routine protocol and found disrupted rhythmic expression of several repair genes, greater endogenous DNA damage at several time points, and increased sensitivity to radiation-induced damage after the night schedule.
That experiment supplies mechanistic evidence, but its limits matter: only seven people followed each schedule, participants were young adults who normally slept at night, and the exposure lasted three days. It shows that circadian misalignment can alter repair processes under tightly controlled conditions; it does not calculate the lifetime health outcome of a particular worker or schedule.
DNA damage is not automatically a permanent genetic change
DNA damage, mutation and altered gene expression are related but distinct findings. A lesion or strand break is physical damage that cells may detect and repair. A mutation is a lasting sequence change that remains after replication or imperfect repair, while gene expression describes how actively a gene is being used without necessarily changing its sequence.
The night-work studies measured breaks, oxidative-damage markers, repair-gene activity or cellular responses to damage. They did not demonstrate that every detected lesion became a mutation. They also did not show that occupational night work created heritable genetic changes in participants’ eggs or sperm, so claims about passing a fixed percentage of damage to the next generation are unsupported by these studies.
This distinction does not make the results irrelevant. Repeatedly creating damage when repair processes are poorly timed is a plausible route to genomic instability, which is why researchers are investigating it as one possible mechanism connecting circadian disruption with disease. Plausibility, however, should not be presented as a diagnosis or a guaranteed chain from one overnight shift to cancer.
What the cancer classification means—and does not mean
The IARC Volume 124 assessment classifies night shift work as probably carcinogenic to humans, or Group 2A. The evaluation, released in 2020 after the 2019 working-group meeting, was based on limited evidence in humans for breast, prostate, colon and rectal cancers, sufficient evidence in experimental animals, and strong mechanistic evidence in experimental systems.
IARC’s classification identifies a hazard; it does not specify the probability that a particular person will develop cancer. Individual risk cannot be inferred without considering the schedule’s duration and pattern, the extent of circadian disruption, and other health and occupational factors. “Probably carcinogenic” therefore should not be translated into “night work will cause cancer,” just as a biomarker change should not be treated as a clinical diagnosis.
The distinction between occasional late work and sustained night-shift exposure also matters. The cancer evaluation concerns work during the population’s usual sleeping hours, while the mechanistic experiments imposed defined overnight schedules. Finishing a project late once is not equivalent to years of rotating or permanent night shifts, although losing sleep can still impair performance the following day.
The 2025 melatonin result is promising but preliminary
A 2025 randomized placebo-controlled trial enrolled 40 night-shift workers and tested 3 mg of melatonin before daytime sleep for four weeks. The melatonin group had an approximately 80% higher urinary concentration of 8-OH-dG during daytime sleep than the placebo group, a borderline statistically significant result interpreted as greater removal and excretion of oxidative DNA lesions. No significant difference appeared during the subsequent night-work period.
This counterintuitive detail is important: in that trial, higher urinary 8-OH-dG was used as a marker of better excision and repair, not as proof that supplementation produced more damage. The trial was small, short and focused on a surrogate biomarker. It did not measure mutations, cancer incidence or long-term safety, so it cannot establish melatonin as a cancer-prevention treatment for shift workers.
What workers and employers can act on now
There is no validated workplace DNA test that can convert these findings into a personal risk score, and the evidence does not support panic after an occasional late night. The immediate, established problem is fatigue: current NIOSH fatigue guidance notes that nonstandard schedules can disrupt or shorten sleep, slowing reaction time and impairing attention, short-term memory and judgment.
Managing that risk is a shared occupational responsibility. Employers can examine schedule design, identify tasks where fatigue has severe consequences and build adequate recovery opportunities into staffing plans. Workers can protect a regular daytime sleep period as far as their circumstances allow and raise persistent insomnia, excessive sleepiness or unsafe fatigue with an occupational-health or medical professional.
The most accurate takeaway is therefore neither reassurance nor catastrophe. Night schedules can disturb molecular timing and leave more DNA damage unrepaired at particular points, while long-term cancer evidence remains limited and individual risk is not quantified by the laboratory studies. Protecting sleep and reducing avoidable circadian disruption are reasonable now; claims of permanently rewritten or inherited DNA are not.
Also read:
Subscribe to our newsletter
Get the latest Web3, AI, and crypto news delivered straight to your inbox.